High treatment success rate among multidrug-resistant tuberculosis patients in Myanmar, 2012–2014: a retrospective cohort study
Assessed outcomes among MDR-TB patients registered for treatment in the Yangon and Mandalay Regions
Abstract
Since 2011, Myanmar has adopted domiciliary care for multidrug-resistant tuberculosis (MDR-TB) patients and implemented several patient-support measures such as community-based directly observed treatment, nutritional support and financial incentives for patients and providers. We assessed treatment outcomes among MDR-TB patients registered for treatment in the Yangon and Mandalay Regions of Myanmar during 2012–2014 and factors associated with unfavourable treatment outcomes.
This research was supported by the UK Department for International Development’s Operational Research Capacity Building Programme led by the International Union Against TB and Lung Disease (The Union)
Citation
Thu MK, Kumar AM V, Soe KT, Saw S, Thein S, Mynit Z, Maung HMW, Aung ST. High treatment success rate among multidrug-resistant tuberculosis patients in Myanmar, 2012–2014: a retrospective cohort study. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2018;111:410–7.